Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct 27:11:566124.
doi: 10.3389/fneur.2020.566124. eCollection 2020.

The Role of DNA Methylation in Ischemic Stroke: A Systematic Review

Affiliations

The Role of DNA Methylation in Ischemic Stroke: A Systematic Review

Minyan Zeng et al. Front Neurol. .

Abstract

Background: Knowledge about the classic risk and protective factors of ischemic stroke is accumulating, but the underlying pathogenesis has not yet been fully understood. As emerging evidence indicates that DNA methylation plays a role in the pathological process of cerebral ischemia, this study aims to summarize the evidence of the association between DNA methylation and ischemic stroke. Methods: MEDLINE, EMBASE, PubMed, and Cochrane Central Register of Controlled Trials were searched for eligible studies. The results reported by each study were summarized narratively. Results: A total of 20 studies with 7,014 individuals finally met the inclusion criteria. Three studies focused on global methylation, 11 studies on candidate-gene methylation, and six on epigenome-wide methylation analysis. Long-interspersed nuclear element 1 was found to be hypomethylated in stroke cases in two studies. Another 16 studies reported 37 genes that were differentially methylated between stroke cases and controls. Individuals with ischemic stroke were also reported to have higher acceleration in Hanuum 's epigenetic age compared to controls. Conclusion: DNA methylation might be associated with ischemic stroke and play a role in several pathological pathways. It is potentially a promising biomarker for stroke prevention, diagnosis and treatment, but the current evidence is limited by sample size and cross-sectional or retrospective design. Therefore, studies on large asymptomatic populations with the prospective design are needed to validate the current evidence, explore new pathways and identify novel risk/protective loci.

Keywords: DNA; ischemic; methylation; review; stroke; systematic.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Flowchart of study selection.

Similar articles

Cited by

References

    1. GBD 2016 Neurology Collaborators. Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. (2019) 18:439–58. 10.1016/s1474-4422(19)30034-1 - DOI - PMC - PubMed
    1. Krishnamurthi RV, Moran AE, Feigin VL, Barker-Collo S, Norrving B, Mensah GA, et al. Stroke prevalence, mortality and disability-adjusted life years in adults aged 20-64 years in 1990-2013: data from the global burden of disease 2013 study. Neuroepidemiology. (2015) 45:190–202. 10.1159/000441098 - DOI - PubMed
    1. Feigin VL, Norrving B, Mensah GA. Global Burden of Stroke. Circ Res. (2017) 120:439–48. 10.1161/CIRCRESAHA.116.308413 - DOI - PubMed
    1. Singer J, Gustafson D, Cummings C, Egelko A, Mlabasati J, Conigliaro A, et al. Independent ischemic stroke risk factors in older Americans: a systematic review. Aging (Albany NY). (2019) 11:3392–407. 10.18632/aging.101987 - DOI - PMC - PubMed
    1. Dichgans M, Pulit SL, Rosand J. Stroke genetics: discovery, biology, clinical applications. Lancet Neurol. (2019) 18:587–99. 10.1016/S1474-4422(19)30043-2 - DOI - PubMed

Publication types